Lykan Bioscience’s SMART Manufacturing Facility, Hopkinton, Massachusetts

Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts,...

Aurobindo Pharma to sell US subsidiary to New Mountain Capital affiliate

Indian firm Aurobindo Pharma has entered into a definitive agreement to sell its US subsidiary...

Twist and Neogene partner to develop next-gen T cell therapies

Twist Bioscience will be supporting Neogene to develop novel, personalised T cell therapies with its...

ANA Therapeutics begins trial of oral niclosamide for Covid-19 treatment

Biotech firm ANA Therapeutics has begun Phase II/III trial to analyse the safety and efficacy...

US election: where do the candidates stand on Covid-19 response?

Unsurprisingly, Covid-19 is dominating the agenda in this US election, with Donald Trump defending his...

Gilead Sciences acquires Immunomedics in $21bn deal

Gilead Sciences has completed the previously announced acquisition of cancer therapies developer Immunomedics for approximately...

With election days away, speed of Covid-19 approvals hangs in the balance

AstraZeneca gets FDA approval to restart Phase III Covid-19 vaccine trial

The US Food and Drug Administration (FDA) has authorised the restart of Phase III clinical...

CPhI 2020: As first Covid-19 vaccines file for approval in EU and Canada, what can CMOs expect?

Purdue Pharma reaches agreement with DOJ over opioid medicines

Purdue Pharma has reached a $8.3bn settlement agreement with the United States Department of Justice...